Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01885728 · ClinicalTrials.gov registry record · NA
Immune-modulation Effects of an Arginine Rich Nutritional Supplement in Surgical Patients
A NA study, sponsored by Martin Angst.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT01885728 is a NA study that has completed, run by Martin Angst. The registered enrollment target is 22 participants.
The verdict
NCT01885728, a NA study, has completed, sponsored by Martin Angst.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
The primary objective of this study is to characterize the immune-modulatory effects of arginine-rich nutritional supplements in patients undergoing surgery. Numerical and functional changes of all circulating immune cells will be assessed with mass cytometry.
Interventions
- DIETARY_SUPPLEMENT An arginine rich nutritional supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2013-07 |
| Est. Completion | 2016-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01885728
The ClinicalTrials.gov registry entry for NCT01885728 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Martin Angst, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which An arginine rich nutritional supplement is the first listed.
NCT01885728 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01885728 about?
NCT01885728 is a clinical study titled "Immune-modulation Effects of an Arginine Rich Nutritional Supplement in Surgical Patients". The primary objective of this study is to characterize the immune-modulatory effects of arginine-rich nutritional supplements in patients undergoing surgery. Numerical and functional changes of all circulating immune cells will be assessed with mass cytometry.
What is the current status of trial NCT01885728?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2013-07. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01885728?
The interventions under investigation include: An arginine rich nutritional supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01885728?
This trial is sponsored by Martin Angst, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.